Page last updated: 2024-09-05

erlotinib hydrochloride and Acoustic Neuroma

erlotinib hydrochloride has been researched along with Acoustic Neuroma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, JJ; Diggelmann, HR; Hansen, MR; Hansen, SS; Provenzano, M; Xu, N	1
Barker, FG; Batchelor, TT; Halpin, C; Loeffler, JS; McKenna, MJ; Plotkin, SR	1
Burns, SS; Bush, ML; Chang, LS; Davletova, S; Jacob, A; Oblinger, J; Welling, DB	1
Plotkin, SR; Terry, AR	1

Reviews

1 review(s) available for erlotinib hydrochloride and Acoustic Neuroma

Article	Year
Chemotherapy: present and future. Otolaryngologic clinics of North America, 2012, Volume: 45, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials, Phase II as Topic; ErbB Receptors; Erlotinib Hydrochloride; Evidence-Based Medicine; Female; Follow-Up Studies; Forecasting; Humans; Magnetic Resonance Imaging; Male; Molecular Targeted Therapy; Neurofibromatosis 2; Neuroma, Acoustic; Quinazolines; Radiosurgery; Risk Assessment; Treatment Outcome	2012

Article

Year

Chemotherapy: present and future.

Otolaryngologic clinics of North America, 2012, Volume: 45, Issue:2

Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials, Phase II as Topic; ErbB Receptors; Erlotinib Hydrochloride; Evidence-Based Medicine; Female; Follow-Up Studies; Forecasting; Humans; Magnetic Resonance Imaging; Male; Molecular Targeted Therapy; Neurofibromatosis 2; Neuroma, Acoustic; Quinazolines; Radiosurgery; Risk Assessment; Treatment Outcome

2012

Other Studies

3 other study(ies) available for erlotinib hydrochloride and Acoustic Neuroma

Article	Year
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2008, Volume: 29, Issue:6 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Death; Cell Proliferation; Erlotinib Hydrochloride; Fluorescent Antibody Technique; Genes, erbB; Magnetic Resonance Imaging; Mice; Mice, Nude; Neuroma, Acoustic; Protein Kinase Inhibitors; Quinazolines; Trastuzumab	2008
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2010, Volume: 31, Issue:7 Topics: Adolescent; Adult; Antineoplastic Agents; Audiometry, Pure-Tone; Disease Progression; Erlotinib Hydrochloride; Female; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Quinazolines; Speech Perception; Treatment Outcome; Young Adult	2010
Treatment of vestibular schwannoma cells with ErbB inhibitors. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2012, Volume: 33, Issue:2 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Ear Neoplasms; Erlotinib Hydrochloride; Humans; Immunohistochemistry; Lapatinib; Neuroma, Acoustic; Oncogene Proteins v-erbB; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Vestibular Nerve	2012